Usana Health Sciences (USNA) Cash from Operations (2016 - 2026)
Usana Health Sciences has reported Cash from Operations over the past 16 years, most recently at 9759000.0 for Q2 2026.
- Quarterly Cash from Operations fell 36.97% to 9759000.0 in Q2 2026 from the year-ago period, while the trailing twelve-month figure was 16626000.0 through Apr 2026, down 71.72% year-over-year, with the annual reading at 22349000.0 for FY2026, 63.36% down from the prior year.
- Cash from Operations was 9759000.0 for Q2 2026 at Usana Health Sciences, up from 3390000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 40463000.0 in Q4 2022 and troughed at 3390000.0 in Q1 2026.
- The 5-year median for Cash from Operations is 13723000.0 (2022), against an average of 15354666.67.
- Year-over-year, Cash from Operations surged 362.91% in 2022 and then crashed 158.6% in 2026.
- A 5-year view of Cash from Operations shows it stood at 40463000.0 in 2022, then tumbled by 35.69% to 26023000.0 in 2023, then crashed by 77.77% to 5785000.0 in 2024, then plummeted by 133.9% to 1961000.0 in 2025, then surged by 597.65% to 9759000.0 in 2026.
- Per Business Quant, the three most recent readings for USNA's Cash from Operations are 9759000.0 (Q2 2026), 3390000.0 (Q1 2026), and 1961000.0 (Q3 2025).